CHICAGO, ILLINOIS--(Marketwire - July 30, 2008) - Allon Therapeutics Inc. (TSX:NPC) - Clinical trial data presented today to two scientific workshops at the International Conference on Alzheimer’s Disease and Related Disorders (ICAD 2008) validate the therapeutic potential of addressing the “tangles” component of the classic Alzheimer’s “plaques and tangles” pathology.
